Cas no 1261909-02-7 (4-(2-Fluoro-4-methoxycarbonylphenyl)-3-methoxybenzoic acid)

4-(2-Fluoro-4-methoxycarbonylphenyl)-3-methoxybenzoic acid structure
1261909-02-7 structure
Product Name:4-(2-Fluoro-4-methoxycarbonylphenyl)-3-methoxybenzoic acid
CAS No:1261909-02-7
MF:C16H13FO5
MW:304.269828557968
MDL:MFCD18322075
CID:2762780
PubChem ID:53227905
Update Time:2025-10-29

4-(2-Fluoro-4-methoxycarbonylphenyl)-3-methoxybenzoic acid Chemical and Physical Properties

Names and Identifiers

    • 1261909-02-7
    • MFCD18322075
    • 4-(2-FLUORO-4-METHOXYCARBONYLPHENYL)-3-METHOXYBENZOIC ACID
    • 2'-Fluoro-2-methoxy-4'-(methoxycarbonyl)[1,1'-biphenyl]-4-carboxylic acid
    • DTXSID60691438
    • 4-(2-Fluoro-4-methoxycarbonylphenyl)-3-methoxybenzoic acid, 95%
    • 4-(2-Fluoro-4-methoxycarbonylphenyl)-3-methoxybenzoic acid
    • MDL: MFCD18322075
    • Inchi: 1S/C16H13FO5/c1-21-14-8-9(15(18)19)3-6-12(14)11-5-4-10(7-13(11)17)16(20)22-2/h3-8H,1-2H3,(H,18,19)
    • InChI Key: FQOPUEITRCCRQN-UHFFFAOYSA-N
    • SMILES: FC1C=C(C(=O)OC)C=CC=1C1C=CC(C(=O)O)=CC=1OC

Computed Properties

  • Exact Mass: 304.07470167Da
  • Monoisotopic Mass: 304.07470167Da
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 1
  • Hydrogen Bond Acceptor Count: 6
  • Heavy Atom Count: 22
  • Rotatable Bond Count: 5
  • Complexity: 413
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 3
  • Topological Polar Surface Area: 72.8?2

4-(2-Fluoro-4-methoxycarbonylphenyl)-3-methoxybenzoic acid Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
abcr
AB329350-5g
4-(2-Fluoro-4-methoxycarbonylphenyl)-3-methoxybenzoic acid, 95%; .
1261909-02-7 95%
5g
€1159.00 2025-04-21
abcr
AB329350-5 g
4-(2-Fluoro-4-methoxycarbonylphenyl)-3-methoxybenzoic acid, 95%; .
1261909-02-7 95%
5g
€1159.00 2023-04-26

Additional information on 4-(2-Fluoro-4-methoxycarbonylphenyl)-3-methoxybenzoic acid

4-(2-Fluoro-4-methoxycarbonylphenyl)-3-methoxybenzoic acid (CAS 1261909-02-7): A Comprehensive Technical Overview

4-(2-Fluoro-4-methoxycarbonylphenyl)-3-methoxybenzoic acid (CAS 1261909-02-7) is an important fluorinated aromatic compound with significant applications in pharmaceutical research and material science. This methoxy-substituted benzoic acid derivative has gained attention in recent years due to its unique structural features and potential as a building block for advanced materials.

The molecular structure of 4-(2-Fluoro-4-methoxycarbonylphenyl)-3-methoxybenzoic acid combines a fluorinated benzene ring with methoxycarbonyl and methoxy substituents, creating a versatile scaffold for chemical modifications. This compound is particularly interesting to researchers developing small molecule pharmaceuticals and organic electronic materials, as evidenced by its growing presence in scientific literature and patent applications.

Recent studies highlight the potential of CAS 1261909-02-7 in the development of targeted drug delivery systems and biocompatible materials. The presence of both fluorine atoms and ester functionalities in its structure makes it valuable for creating compounds with improved metabolic stability and bioavailability - key considerations in modern pharmaceutical development.

In material science applications, 4-(2-Fluoro-4-methoxycarbonylphenyl)-3-methoxybenzoic acid serves as a precursor for liquid crystal materials and organic semiconductors. The fluorine substitution pattern influences the electronic properties of resulting materials, making it particularly useful for designing OLED components and photovoltaic materials - areas experiencing rapid growth due to renewable energy initiatives.

The synthesis of CAS 1261909-02-7 typically involves multi-step organic reactions including Suzuki coupling and esterification processes. Recent advances in green chemistry approaches have focused on optimizing these synthetic routes to improve yields while reducing environmental impact, addressing growing concerns about sustainable chemical production.

Analytical characterization of 4-(2-Fluoro-4-methoxycarbonylphenyl)-3-methoxybenzoic acid employs standard techniques such as HPLC, NMR spectroscopy, and mass spectrometry. The compound typically appears as a white to off-white crystalline powder with specific solubility characteristics that make it suitable for various formulation applications in research settings.

Quality control parameters for CAS 1261909-02-7 include rigorous testing for purity levels (typically ≥95% by HPLC), residual solvents, and heavy metal content. These specifications are particularly important for pharmaceutical applications where compound consistency directly impacts research outcomes.

Storage recommendations for 4-(2-Fluoro-4-methoxycarbonylphenyl)-3-methoxybenzoic acid emphasize protection from moisture and light, with optimal conditions being 2-8°C in tightly sealed containers. Proper handling procedures include standard laboratory precautions for organic compounds, with particular attention to avoiding inhalation of dust particles.

The global market for fluorinated aromatic compounds like CAS 1261909-02-7 has shown steady growth, driven by increasing demand from the pharmaceutical intermediate sector and advanced materials industry. Market analysts project continued expansion as applications in medicinal chemistry and organic electronics continue to develop.

Current research trends involving 4-(2-Fluoro-4-methoxycarbonylphenyl)-3-methoxybenzoic acid focus on its potential in cancer therapeutics and neurodegenerative disease research. The compound's ability to serve as a molecular scaffold for drug discovery makes it valuable in these high-priority medical research areas.

For researchers considering CAS 1261909-02-7 for their projects, recent publications demonstrate successful applications in developing kinase inhibitors and GPCR modulators. The compound's structural features allow for strategic modifications that can fine-tune biological activity while maintaining favorable drug-like properties.

Environmental and regulatory considerations for 4-(2-Fluoro-4-methoxycarbonylphenyl)-3-methoxybenzoic acid follow standard protocols for organic research chemicals. While not classified as hazardous under current regulations, responsible disposal methods should be followed according to institutional guidelines for chemical waste management.

Future developments involving CAS 1261909-02-7 may include expanded applications in bioconjugation chemistry and proteolysis targeting chimera (PROTAC) technology. These emerging fields in drug discovery could benefit from the compound's versatile chemical functionality and potential for creating bifunctional molecules.

For procurement of 4-(2-Fluoro-4-methoxycarbonylphenyl)-3-methoxybenzoic acid, researchers should verify supplier credentials and request comprehensive certificates of analysis. The compound is typically available in research quantities from specialty chemical providers, with lead times varying based on current demand and synthesis schedules.

Technical support for working with CAS 1261909-02-7 is available through many chemical suppliers and academic research groups specializing in fluorinated compounds. Recent case studies demonstrate successful scale-up processes for related structures, suggesting potential pathways for larger-scale production if needed.

In conclusion, 4-(2-Fluoro-4-methoxycarbonylphenyl)-3-methoxybenzoic acid represents an important building block in modern chemical research with diverse applications across multiple scientific disciplines. Its unique combination of fluorine substitution and functional group versatility ensures continued relevance in developing innovative solutions for healthcare and advanced materials challenges.

Recommended suppliers
Jinan Hanyu Chemical Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jinan Hanyu Chemical Co.,Ltd.
Hangzhou TSurgeX Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Hangzhou TSurgeX Pharmaceutical Technology Co., Ltd.
PRIBOLAB PTE.LTD
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
PRIBOLAB PTE.LTD
Shenzhen GeneSeqTools Bioscience & Technology Co. Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Shenzhen GeneSeqTools Bioscience & Technology Co. Ltd.
Wuhan Comings Biotechnology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Wuhan Comings Biotechnology Co., Ltd.